勘误：聚合免疫球蛋白受体通过下调LAMB3表达，经AKT-FOXO3/4轴抑制结直肠癌。
Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.
作者信息
Zhang Ding, Huang Hao, Zheng Ting, Zhang Lei, Cui Binbin, Liu Yanlong, Tan Shiheng, Zhao Liyuan, Tian Tian, Gao Lijing, Fu Qingzhen, Cheng Zesong, Zhao Yashuang
机构信息
Department of Epidemiology, School of Public Health, NHC Key Laboratory of Etiology and Epidemiology (23618504), Harbin Medical University, Harbin, China.
Department of Colorectal Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
出版信息
Front Oncol. 2022 Aug 22;12:1012871. doi: 10.3389/fonc.2022.1012871. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fonc.2022.924988.].
摘要
[本文更正了文章的数字对象标识符（DOI）：10.3389/fonc.2022.924988。]
相似文献
1
Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.勘误：聚合免疫球蛋白受体通过下调LAMB3表达，经AKT-FOXO3/4轴抑制结直肠癌。
Front Oncol. 2022 Aug 22;12:1012871. doi: 10.3389/fonc.2022.1012871. eCollection 2022.
2
Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.聚合免疫球蛋白受体通过下调LAMB3表达，经AKT-FOXO3/4轴抑制结直肠癌。
Front Oncol. 2022 Aug 5;12:924988. doi: 10.3389/fonc.2022.924988. eCollection 2022.
3
LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.LAMB3 通过 AKT-FOXO3/4 轴促进肿瘤进展，并在结直肠癌中受 BRD2/乙酰化 ELK4 复合物的转录调控。
Oncogene. 2020 Jun;39(24):4666-4680. doi: 10.1038/s41388-020-1321-5. Epub 2020 May 12.
4
Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.勘误：EXOSC5作为一种新型预后标志物通过激活ERK和AKT通路促进结直肠癌增殖。
Front Oncol. 2021 Apr 9;11:670041. doi: 10.3389/fonc.2021.670041. eCollection 2021.
5
Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.勘误：小檗碱和原花青素低聚物通过调节PI3K-Akt信号通路在结直肠癌中发挥协同作用。
Front Oncol. 2022 Jun 29;12:952180. doi: 10.3389/fonc.2022.952180. eCollection 2022.
6
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.勘误：差异表达分析揭示CLCA1是结直肠癌的一种预后和诊断生物标志物。
Front Oncol. 2020 Dec 18;10:634122. doi: 10.3389/fonc.2020.634122. eCollection 2020.
7
Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.勘误：MELK抑制通过阻断AKT和FOXM1信号通路有效抑制胶质母细胞瘤和癌症干细胞样细胞的生长。
Front Oncol. 2022 Apr 22;12:911817. doi: 10.3389/fonc.2022.911817. eCollection 2022.
8
Corrigendum: Combined Scutellarin and CHNO Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis.勘误：灯盏花素与CHNO联合使用危及胶质瘤的存活：部分与PSEN1/PI3K-AKT信号轴的抑制有关。
Front Oncol. 2022 Mar 7;12:872110. doi: 10.3389/fonc.2022.872110. eCollection 2022.
9
Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis the Wnt/CaMKII Signaling Axis.勘误：青蒿琥酯通过Wnt/CaMKII信号轴抑制脉络膜黑色素瘤血管生成拟态形成和血管生成
Front Oncol. 2022 Mar 1;12:870805. doi: 10.3389/fonc.2022.870805. eCollection 2022.
10
Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.勘误：FGF1异常表达与mTOR-S6K1在结直肠癌中的关联
Front Oncol. 2021 Oct 25;11:792453. doi: 10.3389/fonc.2021.792453. eCollection 2021.
引用本文的文献
1
Transcriptomic Landscape of Paclitaxel-Induced Multidrug Resistance in 3D Cultures of Colon Cancer Cell Line DLD1.结肠癌细胞系DLD1三维培养中紫杉醇诱导的多药耐药的转录组图谱
Int J Mol Sci. 2025 Jul 9;26(14):6580. doi: 10.3390/ijms26146580.
Zotero 插件